# CorNatural

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cornatural

- Industry: Consumer Products
- Headquarters: London, UK
- Website: www.cornatural.com
- Latest round: Seed (Aug 13, 2019)
- Investors on record: 2

## About

CorNatural is dedicated to developing innovative health solutions through synthetic biology and genetic engineering techniques, aiming to lower the costs associated with healthcare procedures while enhancing product effectiveness.CorNatural specializes in synthetic biology and genetic engineering solutions. Founded in 2019 in London, UK, by Paulo Puterman, the company has completed one significant deal as of August 13, 2019. There are no known subsidiaries or pivots in their strategy.CorNatural focuses on innovative solutions using synthetic biology and genetic engineering to reduce healthcare costs. Their offerings are aimed at healthcare providers, pharmaceutical firms, and research institutions in North America and Europe, addressing various health challenges with a range of bioengineered solutions designed for scalability.CorNatural generates revenue through partnerships and direct transactions within the healthcare sector, developing tailored solutions for clients based on value-driven pricing. Their flagship products are oriented towards large-scale healthcare providers, fostering long-term relationships that contribute to stable revenue streams.CorNatural plans to leverage recent funding acquired in August 2019 from investors RebelBio and SOSV to expand its product offerings and market reach. The company aims to design new solutions targeted for launch in the upcoming years while exploring opportunities for expansion into additional markets in Europe and North America by 2023.

## Funding rounds

- Seed, Aug 13, 2019 — SOSV, RebelBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- RebelBio — Seed